Studies have already included over 140,000 real-time messages sent to electronic data capture and clinical trial management software with the majority of projects still ongoing
ClinPhone reports that it has performed over 60 integration projects to date.
With the continued growth in popularity of clinical systems, the company has recognised the need for sponsors to share important data seamlessly with various third party and in-house systems and software.
Consequently it has developed ClinPhone Connect for both electronic data capture (EDC) and clinical trial management software (CTMS) applications.
Using ClinPhone Connect, a unique integration platform, these studies have already included over 140,000 real-time messages sent to EDC and CTMS with the majority of projects still ongoing.
These studies have involved integrations with a variety of clinical systems including five different EDC solutions.
Following the explosion of electronic data capture as a clinical system, ClinPhone developed its flexible integration solution for EDC to satisfy the growing demand.
ClinPhone Connect for EDC enables studies using the company's interactive voice response (IVR) and interactive web response (IWR) services to exchange data in real time with EDC software.
It also offers protocol-specific touch-points, allowing the rapid set up of communications with most eClinical solutions.
This innovative technology uses a customised approach to clinical trials which ensures optimal integration configuration for each individual study design.
Traditional clinical technology processes can often touch on the same data points in areas such as randomisation codes, patient status and stratification factors.
By allowing data to originate in either the IVR/IWR or EDC systems, ClinPhone Connect eliminates the need for duplicate records and discrepancy resolution, thereby reducing the potential for confusing information and time wastage, it is claimed.
This may also lead to a faster database lock.
Industry estimates show that on average, every day a clinical trial over-runs, a cost of more than US$40,000 is incurred.
Therefore, by eliminating redundant tasks, ClinPhone Connect can provide bio-pharmaceutical companies with substantial cost benefits.
Further key advantages of using ClinPhone Connect for EDC are the real-time accurate data acquisition and the streamlined and accelerated workflows.
Another major benefit of ClinPhone Connect is the possible integration of IVR electronic patient reported outcome (ePRO) data and electronic case report forms (eCRF).
This is extremely beneficial as it is a regulatory requirement for investigators to have access to ePRO source data and review it along with other clinical data collected on the patient.
It is estimated that the bio-pharmaceutical industry spends more than $150 million per year on data exchange.
By using ClinPhone Connect for EDC to integrate key clinical systems, sponsors can eliminate the previous ad hoc movement of clinical information between systems, thereby achieving substantial cost benefits, says the company.
